Need Assistance?
  • US & Canada:
    +
  • UK: +

XT-7

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Antimicrobial peptide 7 is an antimicrobial peptide found in Xenopus tropicalis skin secretions (Western clawed frog, Silurana tropicalis). It has antibacterial and antifungal activity.

Category
Functional Peptides
Catalog number
BAT-013109
CAS number
398143-86-7
Molecular Formula
C83H150N22O20
Molecular Weight
1776.25
IUPAC Name
(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]propanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoic acid
Synonyms
Antimicrobial peptide 7; Gly-Leu-Leu-Gly-Pro-Leu-Leu-Lys-Ile-Ala-Ala-Lys-Val-Gly-Ser-Asn-Leu-Leu-NH2; glycyl-L-leucyl-L-leucyl-glycyl-L-prolyl-L-leucyl-L-leucyl-L-lysyl-L-isoleucyl-L-alanyl-L-alanyl-L-lysyl-L-valyl-glycyl-L-seryl-L-asparagyl-L-leucyl-L-leucinamide; Xenopus tropicalis antimicrobial peptide 7
Appearance
Lyophilized Powder or Liquid
Purity
>96%
Sequence
GLLGPLLKIAAKVGSNLL-NH2
Storage
Store at -20°C
InChI
InChI=1S/C83H149N21O21/c1-19-49(16)68(103-73(114)53(26-21-23-29-85)95-75(116)56(33-44(6)7)97-76(117)58(35-46(10)11)100-80(121)62-27-24-30-104(62)66(109)40-89-71(112)54(31-42(2)3)96-74(115)55(32-43(4)5)92-64(107)38-86)82(123)91-50(17)69(110)90-51(18)70(111)94-52(25-20-22-28-84)72(113)102-67(48(14)15)81(122)88-39-65(108)93-61(41-105)79(120)99-59(37-63(87)106)78(119)98-57(34-45(8)9)77(118)101-60(83(124)125)36-47(12)13/h42-62,67-68,105H,19-41,84-86H2,1-18H3,(H2,87,106)(H,88,122)(H,89,112)(H,90,110)(H,91,123)(H,92,107)(H,93,108)(H,94,111)(H,95,116)(H,96,115)(H,97,117)(H,98,119)(H,99,120)(H,100,121)(H,101,118)(H,102,113)(H,103,114)(H,124,125)/t49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,67-,68-/m0/s1
InChI Key
ABICORAZLFLVBV-LNKKQIGMSA-N
Canonical SMILES
CCC(C)C(C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)CN
1. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7
J Michael Conlon, Sehamuddin Galadari, Haider Raza, Eric Condamine Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.
The frog skin peptides, ascaphin-8 (GFKDLLKGAAKALVKTVLF.NH(2)) and XT-7 (GLLGPLLKIAAKVGSNLL.NH(2)), show broad-spectrum antimicrobial activity but their therapeutic potential is limited by toxicity against mammalian cells. Circular dichroism spectra demonstrate that the peptides adopt an amphipathic alpha-helical conformation in a membrane-mimetic solvent. This study has investigated the cytolytic properties of analogs containing selected amino acid substitutions that increase cationicity while maintaining amphipathicity. Substitutions at Ala(10), Val(14), and Leu(18) in ascaphin-8 by either L-Lys or D-Lys produced peptides that retained antimicrobial activity against the bacteria Escherichia coli and Staphylococcus aureus and the opportunistic yeast pathogen, Candida albicans but showed appreciably reduced toxicities (>10-fold) against human erythrocytes, HepG2 hepatoma-derived cells, and L929 fibroblasts. The improved therapeutic index of the L-Lys(18) and D-Lys(18) analogs correlated with a decrease in % helicity and in effective hydrophobicity. Substitution of Gly(4) by L-Lys in XT-7 produced an analog with high potency against micro-organisms (MIC < or = 25 microM) but low cytolytic activity against erythrocytes (LD(50) > 500 microM) and this increase in therapeutic index also correlated with decreased helicity and hydrophobicity. Analogs of XT-7 with increased cationicity, containing multiple substitutions by L-Lys, not only displayed increased antimicrobial potencies, particularly against Candida albicans (MIC < or = 6 microM), but also increased hemolytic activities.
2. Tensile dislodgment evaluation of two experimental prefabricated post systems
X Lepe, D J Bales, G H Johnson Oper Dent. 1996 Sep-Oct;21(5):209-12.
This study tested the tensile dislodgment forces of two experimental post designs that are threaded 7 mm into the most coronal aspect of the root. Experimental post systems ParaPost XT-7 (XT-7), and ParaPost XT-10 (XT-10) were compared to the Flexi-Post (FP) and to the Standard ParaPost (SP). The XT-7 prototype post measured 7 mm in length, while all other post systems were 10 mm. The XT-7 and the FP are active post systems that are threaded throughout their entire length. The SP is a passive serrated post system, and the XT-10 is a combination active/passive design that has a 7 mm coronal thread with a passive serrated apical end. All systems tested were titanium alloy except the SP system, which was stainless steel. The purpose of this study was to compare an active and a passive post design to the experimental designs of the XT-7 active post and the combined active/passive design of the XT-10. This study clearly demonstrated highest retention for the active post system, least retention for the passive post, with an intermediate retentiveness for the combined design.
3. Development of potent anti-infective agents from Silurana tropicalis: conformational analysis of the amphipathic, alpha-helical antimicrobial peptide XT-7 and its non-haemolytic analogue [G4K]XT-7
Anusha P Subasinghage, J Michael Conlon, Chandralal M Hewage Biochim Biophys Acta. 2010 Apr;1804(4):1020-8. doi: 10.1016/j.bbapap.2010.01.015. Epub 2010 Jan 29.
Peptide XT-7 (GLLGP(5)LLKIA(10)AKVGS(15)NLL.NH(2)) is a cationic, leucine-rich peptide, first isolated from skin secretions of the frog, Silurana tropicalis (Pipidae). The peptide shows potent, broad-spectrum antimicrobial activity but its therapeutic potential is limited by haemolytic activity (LC(50)=140 microM). The analogue [G4K]XT-7, however, retains potent antimicrobial activity but is non-haemolytic (LC(50)>500 microM). In order to elucidate the molecular basis for this difference in properties, the three dimensional structures of XT-7 and the analogue have been investigated by proton NMR spectroscopy and molecular modelling. In aqueous solution, both peptides lack secondary structure. In a 2,2,2-trifluoroethanol (TFE-d(3))-H(2)O mixed solvent system, XT-7 is characterised by a right handed alpha-helical conformation between residues Leu(3) and Leu(17) whereas [G4K]XT-7 adopts a more restricted alpha-helical conformation between residues Leu(6) and Leu(17). A similar conformation for XT-7 in 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) micellular media was observed with a helical segment between Leu(3) and Leu(17). However, differences in side chain orientations restricting the hydrophilic residues to a smaller patch resulted in an increased hydrophobic surface relative to the conformation in TFE-H(2)O. Molecular modelling of the structures obtained in our study demonstrates the amphipathic character of the helical segments. It is proposed that the marked decrease in haemolytic activity produced by the substitution Gly(4)-->Lys in XT-7 arises from a decrease in both helicity and hydrophobicity. These studies may facilitate the development of potent but non-toxic anti-infective agents based upon the structure of XT-7.
Online Inquiry
Verification code
Inquiry Basket